Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains

CRISPR-Cas9 genome editing technology holds great promise for discovering therapeutic targets in cancer and other diseases. Current screening strategies target CRISPR-induced mutations to the 5’ exons of candidate genes(1–5), but this approach often produces in-frame variants that retain functionali...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Junwei, Wang, Eric, Milazzo, Joseph P., Wang, Zhihua, Kinney, Justin B., Vakoc, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529991/
https://www.ncbi.nlm.nih.gov/pubmed/25961408
http://dx.doi.org/10.1038/nbt.3235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529991/
https://www.ncbi.nlm.nih.gov/pubmed/25961408
http://dx.doi.org/10.1038/nbt.3235

Ejemplares similares